Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Periodontol 2000 ; 2024 Feb 27.
Artículo en Inglés | MEDLINE | ID: mdl-38411337

RESUMEN

The mucosa of the oral cavity is exposed to a large number of different microorganisms such as archaea, bacteria, fungi, parasites, and viruses. Among those, viruses cause specific infections, which can easily be transmitted from one person to another. The infectious route may not only include patients and their relatives but also the dental professional team. Thus, a wide knowledge regarding specific viral infections is crucial for the daily routine. Signs and symptoms of oral viral infections can be completely absent or develop into a pronounced clinical picture, so that early detection and information determine the further course of the infection and its influence on other inflammatory diseases, such as periodontitis, as well as the safety of family members and the social environment. As the clinical manifestation of viral infections may be highly variable leading to heterogenous mucosal lesions it is, in most cases, mandatory to differentiate them by specific microbiological tests in addition to clinical examination procedures. This article will give an overview of the role of viruses infecting the oral mucosa, and in addition, describe their clinical manifestation and management.

2.
Cancers (Basel) ; 14(23)2022 Dec 06.
Artículo en Inglés | MEDLINE | ID: mdl-36497491

RESUMEN

Background: Recurrent aphthous stomatitis (RAS) is found among the most frequent diseases of the oral cavity. It is characterized by repeated formation of painful ulcers. The question has risen if due to potential tumor-promoting inflammation and sustaining proliferative signaling RAS may contribute to oral cancer. Accordingly, the aim of the study was to assess if an association of RAS and the development oral squamous cell carcinoma (OSCC) could be found in a larger cohort. As recurrent aphthous stomatitis is not classified as an oral potentially malignant disorder, it was assumed that the risk of OSCC did not differ between patients with (cohort I) and without RAS (cohort II). Methods: Retrospective clinical data of patients diagnosed with and without RAS (International Classification of Diseases (ICD)-10 code K12) within the past 20 years and a body mass index of 19−30 kg/m2 were retrieved from the TriNetX database to gain initial cohort 0. Subjects suffering from RAS were assigned to cohort I, whereby cohort II was obtained from the remaining individuals, and by matching for age, gender, as well as (history of) nicotine and alcohol dependence. After defining the primary outcome as "OSCC" (ICD-10 codes C00-C14), a Kaplan−Meier analysis was performed, and risk and odds ratios were calculated. Results: Of a total of 24,550,479 individuals in cohort 0, 72,845 subjects were each assigned to cohort I (females: 44,031 (60.44%); males: 28,814 (39.56%); mean current age (±standard deviation) = 35.51 ± 23.55 years) and II (females: 44,032 (60.45%); males: 28,813 (39.55%); mean current age (±standard deviation) = 35.51 ± 23.56 years). Among the cohorts I and II, 470 and 135 patients were diagnosed with OSCC within five years. The according risk of developing oral cancer was 0.65% and 0.18%, whereby the risk difference of 0.47% was highly significant (p < 0.0001; Log-Rank test). The RR and OR were calculated as 3.48 (95% confidence interval (CI) lower: 2.88 and upper: 4.21) and 3.50 (95% CI lower: 2.89 and upper: 4.24). Conclusions: Among the patients suffering from RAS, a significantly augmented risk of developing OSCC was found. However, it has to be emphasized that the recent literature does not provide any confirmatory evidence that supports the retrieved results. Furthermore, the findings need to be interpreted cautiously due to specific limitations that come along with the applied methods. It should thus far only be concluded that further research is necessary to evaluate hypotheses that may be retrieved from the obtained results. Despite this controversy, oral ulcers suspicious of OSCC should undergo biopsy. Trial Registration: Due to the retrospective nature of the study, no registration was necessary.

3.
BMC Cancer ; 22(1): 454, 2022 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-35468757

RESUMEN

BACKGROUND: Syphilis is an infectious disease that is at least discussed to be premalignant. This potential, combined with its general pathological impact, raises the question if syphilis increases mortality in oral cancer patients. The aim of the study was to assess if the five-year survival rates among patients suffering from oral squamous cell carcinoma (OSCC) with (cohort I) and without association with syphilis (cohort II) differ. METHODS: Retrospective clinical data of patients diagnosed with OSCC (International Classification of Diseases [ICD]-10 codes C01-06) within the past 20 years from the access date September 25, 2021 were retrieved from the TriNetX network (TriNetX, Cambridge, Massachusetts, USA) to gain initial cohort 0. Subjects also diagnosed with syphilis (ICD-10 codes A51-53) were assigned to cohort I. Cohort II was comprised of the remaining individuals of cohort 0 by creating a group with the same number of patients as cohort I, and by matching for age and gender. Subsequently, Kaplan-Meier analysis and Cox proportional hazards regression were performed, and risk, odds and hazard ratios were calculated. RESULTS: Of a total of 73,736 patients in cohort 0, 199 individuals were each assigned to cohort I and II. During the five-year period after tumor diagnosis, 39 and 30 patients in cohort I and II died. The five-year survival probabilities did not significantly differ between the cohorts (I vs. II = 74.19% vs. 75.01%; p = 0.52; Log-Rank test), nor the risk of dying (I vs. II = 19.6% vs. 15.08%; risk difference = 4.52%; p = 0.23). The calculated risk, odds and hazard ratios were 1.3 (95% confidence interval [CI] = 0.84; 2.00), 1.37 (95% CI = 0.81; 2.31) and 1.17 (95% CI = 0.73; 1.88), respectively. CONCLUSIONS: The obtained results indicate that the survival rate of individuals with OSCC might not be negatively influenced if syphilis is present/associated. However, the results need to be interpreted cautiously due to limitations related to the retrospective approach, especially as data on the tumor staging were not accessible. TRIAL REGISTRATION: Due to the retrospective nature of the study, no registration was necessary.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias de Cabeza y Cuello , Neoplasias de la Boca , Sífilis , Carcinoma de Células Escamosas/patología , Estudios de Casos y Controles , Neoplasias de Cabeza y Cuello/patología , Humanos , Neoplasias de la Boca/patología , Estadificación de Neoplasias , Pronóstico , Estudios Retrospectivos , Carcinoma de Células Escamosas de Cabeza y Cuello/patología , Tasa de Supervivencia , Sífilis/complicaciones , Sífilis/epidemiología , Sífilis/patología
4.
Vaccines (Basel) ; 10(3)2022 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-35335112

RESUMEN

Introduction: Onset of oral lichenoid lesions (OLL) or oral lichen planus (OLP) can be rare adverse reactions to vaccines. Recently, the first solitary cases were reported after COVID-19 vaccination. The aim of the present study was to assess if an increased frequency of OLL/OLP can be found after COVID-19 vaccination within a large real-world cohort. It was assumed that the incidence of OLL/OLP was significantly higher in subjects who received COVID-19 vaccine (cohort I) compared to individuals who were not vaccinated (cohort II). Patients and Methods: Initial cohorts of 274,481 vaccinated and 9,429,892 not vaccinated patients were retrieved from the TriNetX database (TriNetX, Cambridge, Massachusetts, USA), and matched for age, gender and the frequency of use of non-steroidal anti-inflammatory drugs, beta blockers, and angiotensin-converting enzyme inhibitors. Results: After matching each cohort, we accounted for 217,863 patients. Among cohort I, 146 individuals had developed OLL/OLP within 6 days after COVID-19 vaccination (88 and 58 subjects had received mRNA- and adenovirus vector-based vaccines), whereas in cohort II, 59 patients were newly diagnosed with OLL/OLP within 6 days after having visited the clinic for any other reason. The risk of developing OLL/OLP was calculated as 0.067% vs. 0.027%, for cohorts I and II, whereby the risk difference was highly significant (p < 0.001; log-rank test). RR and OR were 2.475 (95% CI = 1.829; 3.348) and 2.476 (95% CI = 1.830; 3.350), respectively. Discussion: The hypothesis was confirmed. Accordingly, the obtained results suggest that the onset of OLL/OLP is a rare adverse drug reaction to COVID-19 vaccines, especially to mRNA vaccines. Thus far, it remains unknown if specific components of the formulations cause a type IV hypersensitive reaction corresponding to OLL, or if the immune response post vaccination triggers a T cell-driven autoimmune reaction directed against the basal layer of keratinocytes of the oral mucosa in terms of OLP. Although OLL and OLP are both classified as premalignant lesions, spontaneous remission may be expected over time, at least in the case of OLL. Therefore, the presented findings should not place any limitation toward the use of COVID-19-vaccines in broad levels of the population.

5.
Clin Oral Investig ; 26(1): 333-342, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34142239

RESUMEN

OBJECTIVES: The epidemiologic distribution of non-albicans species in the oral cavity of oral lichen planus (OLP) patients remains uncertain. Therefore, the aim of this study was to identify factors associated with the presence of C. dubliniensis and other non-albicans species. Furthermore, independent risk factors for Candida superinfection in OLP should be identified. MATERIAL AND METHODS: Epidemiologic data and microbiological findings from 268 symptomatic OLP patients who underwent continuous oral swab culture over a 5-year period (2015-2019) were retrospectively reviewed. Candida species identification and semi-quantification were obtained by culture on CHROMagar Candida, followed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). RESULTS: C. albicans was the most frequently isolated species (72.3%), followed by C. glabrata (7.3%), C. dubliniensis (5.8%), C. krusei and C. parapsilosis (both 2.6%). The presence of C. dubliniensis was significantly associated with tobacco smoking. Other non-albicans spp. were significantly more often detected in patients using removable dentures. Increasing age and the intake of psychotropic drugs were identified as independent risk factors of Candida superinfection in OLP. CONCLUSION: In OLP patients, certain local and systemic factors increase the risk of carrying potentially drug-resistant Candida species and the development of Candida superinfection of OLP lesions. CLINICAL RELEVANCE: Due to the frequent detection of non-albicans species in OLP, resistance or at least reduced sensitivity to azole antifungals should be expected, especially in smokers and patients using removable dentures. In the case of oral complaints, a superinfection with Candida should be considered, whereby older patients and patients taking psychotropic drugs have an increased risk for oral infection with Candida.


Asunto(s)
Candidiasis Bucal , Liquen Plano Oral , Candida , Candidiasis Bucal/epidemiología , Humanos , Estudios Retrospectivos
6.
Front Oncol ; 12: 1080492, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36698388

RESUMEN

Background: The question arises if there is an association of psycho-emotional stress and chronic soft tissue injuries caused by bruxism somatoform disorders with oral squamous cell carcinoma (OSCC). Methods: Patients with and without "somatoform disorders including psychogenic disturbances" (International Classification of Diseases [ICD]-10 code F45.8), and/or "unspecific behavioral syndromes" (F59), and/or "sleep related bruxism" (G47.63), and/or "other sleep disorders" (G47.8) were retrieved from the TriNetX network to gain cohort I. Cohort II was formed by patients without the aforementioned diagnoses, and by matching for age, gender, tobacco use, and alcohol abuse. After defining the primary outcome as "OSCC" (ICD-10 codes C00-C14), a Kaplan-Meier analysis was performed, and risk ratio (RR) and odds ratio (OR) were calculated. Results: After matching, each cohort accounted for 154,639 patients (59.7% females; 40.3% males; mean current age (± standard deviation) = 43.4 ± 24.5 years). Among cohorts I and II, 907 and 763 patients, respectively, were diagnosed with OSCC within 5 years (risk of OSCC = 0.6% and 0.5%), whereby the risk difference was significant (p < 0.001; Log-Rank test). RR and OR were 1.19 (95% confidence interval (CI), lower = 1.08 and upper = 1.31) and 1.19 (95% CI, 1.08-1.31). Conclusions: Psycho-emotional stress and/or chronic mucosal injuries may play a role in carcinogenesis. However, the results need to be interpreted cautiously due to limitations of the applied approach. It may thus far only be concluded that further research is necessary to investigate hypotheses regarding psychogenic carcinogenesis and tumor formation due to chronic tissue trauma.

7.
Quintessence Int ; 51(2): 156-161, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31942576

RESUMEN

In recent years, a large number of studies have been published evaluating the therapy of oral lichen planus. In addition to standard medication such as topical glucocorticoid therapy, substances such as Aloe vera, hyaluronic acid, and treatments from traditional Chinese medicine have also been investigated. It is not always easy for dental practitioners to find an adequate therapy according to the clinical picture. This article presents therapies for dental practitioners who do not focus on treating patients with oral mucosa diseases. Oral lichenoid lesions, which are clinically and histologically similar, must be distinguished from oral lichen planus. Before starting therapy, it is necessary to differentiate between drug- and contact-related variants. Both clinical features have in common that according to the World Health Organization (2017) they belong to the class of potentially malignant disorders. Accordingly, these patients must be referred to a regular, and in oral lichen planus patients, lifelong, recall.


Asunto(s)
Liquen Plano Oral , Erupciones Liquenoides , Enfermedades de la Boca , Glucocorticoides , Humanos
8.
BMC Oral Health ; 18(1): 132, 2018 08 03.
Artículo en Inglés | MEDLINE | ID: mdl-30075766

RESUMEN

BACKGROUND: The objectives of this study were to determine the status of oral health among newly arrived refugees in Germany and to explore their knowledge, attitude and practices on oral hygiene. METHODS: All participants (n = 386) were adults, 18-60 years of age, coming from Syria and Iraq and registered as refugees in Germany within one year prior to the enrollment in the study. Clinical oral assessments in addition to a survey on knowledge, attitude and practice were carried out. The survey was conducted through a questionnaire translated into Arabic. RESULTS: Eighty seven point 5 % of the participants had untreated caries. The mean DMFT score was 6.38 with DT, MT and FT showing mean scores of 4.00, 1.46 and 0.92 respectively. Seventy nine percent had bacterial plaque in all six sextants, 60 % had calculus in at least three sextants and 6 % showed various magnitudes of enamel fluorosis. DMFT score was significantly associated with age (Regression Coefficient 0.031, P-value < 0.001) and with education (Regression Coefficient - 0.019, P-value 0.037) and females had significantly less missing teeth (Regression Coefficient-0.398, P-value 0.001) compared to males. The participants had in general high levels of knowledge and attitude on oral hygiene. The findings however showed a gap between their knowledge and practice. CONCLUSIONS: The findings show high prevalence of untreated caries and poor oral hygiene among newly arrived refugees in Germany. The study recommends to lay emphasis on motivation in oral health promotion campaigns among refugees and to provide them with adequate guidance, preferably in their native language, on how to access oral health care in the host country.


Asunto(s)
Salud Bucal/estadística & datos numéricos , Refugiados/estadística & datos numéricos , Adolescente , Adulto , Factores de Edad , Estudios Transversales , Índice CPO , Caries Dental/epidemiología , Placa Dental/epidemiología , Escolaridad , Femenino , Fluorosis Dental/epidemiología , Alemania/epidemiología , Conocimientos, Actitudes y Práctica en Salud , Humanos , Masculino , Persona de Mediana Edad , Higiene Bucal/psicología , Higiene Bucal/estadística & datos numéricos , Factores Sexuales , Pérdida de Diente/epidemiología , Adulto Joven
9.
Clin Oral Investig ; 22(2): 721-731, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28601915

RESUMEN

OBJECTIVES: The aim of the study was to investigate whether specific volatile organic compounds (VOCs) can be detected in oral candidiasis patients using breath analysis in order to develop a point-of-care diagnostic tool. PATIENTS/METHODS: Breath samples of 10 diseased patients and 10 subjects carrying no Candida spp. were analyzed using gas chromatography and mass spectrometry. In infected patients, breath tests were performed before and after antifungal therapy. RESULTS: Breath testing was positive for 143 volatiles in both healthy subjects and diseased patients. Among those, specific signature volatiles known to be emitted by Candida spp. in vitro were not detected. Even though no specific signature was retrieved from the diseased patients, a pattern containing nine compounds (2-methyl-2-butanol, hexanal, longifolene, methyl acetate, 1-heptene, acetophenone, decane, 3-methyl-1-butanol, chlorbenzene) was identified, which showed characteristic changes after antifungal therapy. CONCLUSIONS: Focusing on the identified pattern, breath analysis may be applied to confirm the absence of Candida spp. after therapy in terms of a confirmatory test supplementing clinical examination, thereby replacing microbial testing. However, microbial testing will still be needed to initially confirm clinical diagnoses, as no specific signature was found. CLINICAL RELEVANCE: A breath test may help in avoiding extended antifungal administration resulting in resistance development and might be useful in the monitoring of disease recurrences in vulnerable groups.


Asunto(s)
Candidiasis Bucal/metabolismo , Compuestos Orgánicos Volátiles/análisis , Anciano , Anciano de 80 o más Años , Antifúngicos/uso terapéutico , Pruebas Respiratorias , Candidiasis Bucal/tratamiento farmacológico , Estudios de Casos y Controles , Dentaduras , Femenino , Cromatografía de Gases y Espectrometría de Masas , Humanos , Masculino , Espectrometría de Masas , Persona de Mediana Edad , Proyectos Piloto
10.
Clin Oral Investig ; 22(1): 305-311, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28353022

RESUMEN

OBJECTIVE: The objective of this study was to investigate the effect of topical morphine on erosive/ulcerative lesions in patients with oral lichen planus (OLP). Previous studies reported on an enhanced remission of skin wounds when morphine was applied topically. MATERIALS AND METHODS: This was single-center, prospective, double-blind, placebo-controlled, randomized, multi-arm (3), phase II study (RCT). Patients diagnosed with erosive and/or ulcerative OLP applied 0.2 or 0.4 mg morphine dissolved in glycerine, three times a day for 5 days. The primary outcome was the extent of healing. Secondary outcomes were as follows: (1) effect on pain, (2) presence and severity of opioid-related central and local side effects, (3) whether patients required 'rescue medication' for treatment of pain, and (4) total intake of test substance. RESULTS: A total of 123 patients were screened for eligibility, 45 patients were recruited into the study, and 43 completed it. Patients applied a solution of either placebo or 0.2 or 0.4% morphine in groups of n = 12, n = 15, and n = 16, respectively. Extent of healing was similar in the three groups. Severity of pain was minor pre-treatment and throughout the course of the study. Only minor adverse events were reported (dry mouth, burning sensation). CONCLUSION: Morphine did not enhance wound healing compared to placebo-treated patients. Healing was observed in all groups, which may be attributed to an effect of glycerine or to the natural course of the disease. Patients experienced only mild levels of pain, rendering the model insensitive for assessing pain. CLINICAL RELEVANCE: OLP is a chronic disease and current treatment options are limited. Healing occurred in all three study groups, an effect we attribute to the carrier.


Asunto(s)
Analgésicos Opioides/administración & dosificación , Liquen Plano Oral/tratamiento farmacológico , Morfina/administración & dosificación , Manejo del Dolor/métodos , Cicatrización de Heridas/efectos de los fármacos , Administración Tópica , Adolescente , Adulto , Anciano , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Estudios Prospectivos , Resultado del Tratamiento
11.
Mycoses ; 59(7): 467-75, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26932256

RESUMEN

Extended use of antimycotics in oral candidiasis therapy gives rise to problems related to fungal drug resistance. The aim of this pilot study was to investigate the efficacy of tissue tolerable plasma (TTP) in denture stomatitis patients. It was hypothesised that (I): erythema and (IIa): complaint remission would be accelerated and (IIb): colony forming unit (CFU) reduction would be improved. The halves of the upper jaws of eight patients were randomly assigned to control (nystatin, chlorhexidine and placebo treatment) and test sides (nystatin, chlorhexidine and TTP administered six times each 7 days). The patients and the investigators, who were different from the therapists, were both blinded. Compared to the control sides, the erythema surface was reduced significantly more extensively on the test sides between 2 and 6 weeks of antifungal therapy (P ≤ 0.05). Visual analogue scale values and the frequency of moderate or heavy growth of Candida post-treatment did not differ significantly between both sides (P > 0.05). The primary hypothesis was confirmed, which may be interpreted as an accelerated remission. As drug therapy is usually limited to the time in which signs of infection are present, TTP might help reducing antifungal use. Even though the secondary hypotheses were not confirmed, persistence of Candida might be only colonisation.


Asunto(s)
Candida/efectos de la radiación , Candidiasis Bucal/terapia , Dentaduras/microbiología , Mucosa Bucal/efectos de la radiación , Gases em Plasma/uso terapéutico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antifúngicos/uso terapéutico , Candidiasis Bucal/tratamiento farmacológico , Candidiasis Bucal/microbiología , Clorhexidina/uso terapéutico , Método Doble Ciego , Farmacorresistencia Fúngica , Eritema/microbiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/microbiología , Antisépticos Bucales/uso terapéutico , Nistatina/uso terapéutico , Proyectos Piloto , Adulto Joven
12.
Mycoses ; 59(2): 117-26, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26667499

RESUMEN

Oral candidiasis is the most frequent fungal infection of the oral cavity. Clinical diagnoses require mycological confirmation, which is time-consuming in case of culture testing. The aim of the study was to identify signature volatiles to develop a chairside breath test to diagnose oral candidiasis. Headspaces above Candida albicans, glabrata, tropicalis, krusei cultures, and growth media as control were analysed after eight and 24 h using offline gas chromatography and mass spectrometry. The identification of signature volatiles was assisted using various microbial databases. Retrieved volatile patterns enabled Candida species discrimination in vitro. For C. albicans 3-methyl-2-butanone and styrene and for C. krusei a combination of p-xylene, 2-octanone, 2-heptanone and n-butyl acetate were found to be specific. 1-hexanol was found in C. tropicalis, but is emitted by a variety of other microorganisms. C. glabrata was characterised through the absence of these volatiles. The development of a breath test is a promising approach in confirming suspicions of oral candidiasis. To confirm the retrieved results in vivo, breath tests in affected and healthy subjects have to be performed.


Asunto(s)
Candida/clasificación , Candida/aislamiento & purificación , Candidiasis Bucal/diagnóstico , Compuestos Orgánicos Volátiles/análisis , Acetatos/análisis , Adulto , Pruebas Respiratorias , Candida/química , Candida albicans/clasificación , Candida albicans/aislamiento & purificación , Candida glabrata/clasificación , Candida glabrata/aislamiento & purificación , Candida tropicalis/clasificación , Candida tropicalis/aislamiento & purificación , Candidiasis Bucal/microbiología , Cromatografía de Gases/métodos , Diagnóstico Diferencial , Hexanoles/análisis , Humanos , Cetonas/análisis , Masculino , Espectrometría de Masas/métodos , Pentanonas/análisis , Estireno/análisis , Xilenos/análisis
13.
J Biophotonics ; 9(6): 637-44, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-26349849

RESUMEN

Surface decontamination remains challenging in peri-implant infection therapy. To investigate the bactericidal efficacy of tissue tolerable plasma, S. mitis biofilms were created in vitro on 32 microrough titanium dental implants. Biofilm imaging was performed by confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). The implants were either rinsed with 1% NaCl as negative control (C) or irradiated with a diode laser (DL) for 60 sec as positive control or plasma (TTP60, TTP120) for 60 or 120 sec. Subsequently, colony forming units (CFU) were counted. Post-treatment, implants were further examined using fluorescence microscopy (FM). Median CFU counts differed significantly between TTP60, TTP120 and C (2.19 and 2.2 vs. 3.29 log CFU/ml; p = 0.012 and 0.024). No significant difference was found between TTP60 and TTP120 (p = 0.958). Logarithmic reduction factors were (TTP60) 2.21, (TTP120) 1.93 and (DL) 0.59. Prior to treatment, CLSM and SEM detected adhering bacteria. Post-treatment FM recorded that the number of dead cells was higher using TTP compared to DL and C. In view of TTP's effectiveness, regardless of resistance patterns and absence of surface alteration, its use in peri-implant infection therapy is promising. The results encourage conducting clinical studies to investigate its impact on relevant parameters.


Asunto(s)
Implantes Dentales/microbiología , Desinfección/métodos , Gases em Plasma/farmacología , Titanio , Biopelículas , Humanos , Rayos Láser , Microscopía Electrónica de Rastreo , Propiedades de Superficie
14.
Clin Oral Investig ; 20(7): 1477-86, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26481235

RESUMEN

OBJECTIVES: In order to identify oral candidiasis patients being at risk of carrying potentially drug-resistant Candida, the aim of the study was to detect local, systemic, demographic, and health-related factors influencing (I) yeast spectrum composition and (II) antifungal administration frequency. Additionally, the aim was to investigate (III) species shift occurrence. MATERIALS AND METHODS: Data from 798 patients (496 females, 302 males; mean age 59.7) with oral candidiasis diagnosed based on positive clinical and microbial findings (species identification and CFU count) between 2006 and 2011 were retrospectively analyzed using Pearson's chi(2) test and regression analysis. RESULTS: Among 958 isolates, Candida albicans was the most frequently detected (76.8 %). Also, species intrinsically resistant to azoles were frequently isolated (15.8 and 17.7 % of isolates and patients). (I) Infections only caused by C. albicans were significantly associated with the use of inhalation steroids (p = 0.001) and antibiotics (p = 0.04), super-infection of lichen planus (p = 0.002), and the absence of removable dentures (p < 0.001). (II) Anti-mycotics were significantly more frequently administered in patients using inhalation steroids (p = 0.001), suffering from asthma/COPD, or smoking heavily (p = 0.003) and if C. albicans and non-albicans species were detected together (p = 0.001). (III) Pathogen composition did not change over time within the examined period (p = 0.239). CONCLUSIONS: Different variables enhance the presence of certain Candida and the antifungal prescription frequency. No species shift was evident. CLINICAL RELEVANCE: The major pathogen in oral candidiasis remains C. albicans. Nevertheless, therapeutic problems may be caused by the frequent presence of species intrinsically resistant to azoles, especially in patients wearing dentures.


Asunto(s)
Candidiasis Bucal/etiología , Candidiasis Bucal/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antifúngicos/uso terapéutico , Candida albicans/aislamiento & purificación , Candidiasis Bucal/tratamiento farmacológico , Niño , Recuento de Colonia Microbiana , Dentaduras/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Fumar/efectos adversos , Xerostomía/complicaciones
15.
Clin Oral Investig ; 11(3): 257-65, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17401588

RESUMEN

Primary stability has a major impact on the long-term success of dental implants. The aim of this study was to investigate the correlation of resonance frequency analysis (RFA) and insertion torque of self-tapping and non-self-tapping implants and their respective differences in primary stability. A group of 263 patients were treated with a total of 602 conically formed dental implants: 408 non-self-tapping Ankylos and 194 self-tapping Camlog. The maximum insertion torque during implant placement was recorded. Resonance frequency, measured as the implant stability quotient (ISQ), was assessed once immediately after insertion and twice 3 months later. Torque values of the non-self-tapping implants were significantly higher than those in the self-tapping group (p = 0.023). RFA did not show differences between the 2 groups (p = 0.956), but a correlation between ISQ values after implantation and 3 months after implant placement was measured (r = 0.712). Within the implant systems, no correlation between insertion torque and resonance frequency values could be determined (r = 0.305). Our study indicates that the ISQ values obtained from different implant systems are not comparable. The RFA does not appear suitable for the evaluation of implant stability when used as a single method. Higher insertion torque of the non-self-tapping implants appeared to confirm higher clinical primary stability.


Asunto(s)
Implantes Dentales , Retención de Prótesis Dentales , Oseointegración/fisiología , Adulto , Anciano , Anciano de 80 o más Años , Densidad Ósea/fisiología , Implantación Dental Endoósea/métodos , Diseño de Prótesis Dental , Femenino , Humanos , Masculino , Mandíbula/cirugía , Maxilar/cirugía , Persona de Mediana Edad , Propiedades de Superficie , Torque , Transductores
16.
J Oral Maxillofac Surg ; 65(3): 439-43, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17307590

RESUMEN

PURPOSE: To report the treatment of facial skin defects by cultured epithelial autografts and its clinical outcome. PATIENTS AND METHODS: Between 2002 and 2003, 18 patients with secondary facial skin defects (after tumor excision, trauma, or due to chronic wound healing dysfunction) were successfully treated with autologous cultivated keratinocytes. Overall, 12 patients were included in our study. At the time of this evaluation, the average time lapse after treatment with autologous cultivated keratinocytes was 13.1 months. From 9 of 12 patients a skin biopsy was taken, 12 of 12 patients were neurologically tested, and the results of 12 of 12 patients' esthetics were evaluated by photography and in written form with a standardized questionnaire. RESULTS: Histologically, 9 of 12 patients showed a regular epithelial layer with evidence of basal cells of the basal membrane and conspicuously arranged connective tissue. The neurologic quality of the skin was discreetly reduced in 9 of 12 patients, but this was not experienced by the patient as a limitation. The wound closure was permanent in the case of all 12 patients. Scar tissue was found frequently, when the wound size was greater than 2.5 cm2. On the basis of the standardized questionnaire, 12 of 12 patients rated the degrees of their subjective satisfaction. CONCLUSION: From the esthetic, histologic, and neurologic points of view, cultured epithelial autografts are an auspicious alternative to conventional grafting methods for facial skin replacement. Optimizing cell growth in vitro to decrease the cultivation period still remains an essential goal for the future to increase patient acceptance of the procedure as well.


Asunto(s)
Técnicas de Cultivo de Célula , Cara/cirugía , Queratinocitos/trasplante , Trasplante de Piel/métodos , Ingeniería de Tejidos/métodos , Adulto , Anciano , Anciano de 80 o más Años , Células Cultivadas/trasplante , Estética , Cara/inervación , Traumatismos Faciales/cirugía , Neoplasias Faciales/cirugía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Satisfacción del Paciente , Procedimientos de Cirugía Plástica/métodos , Procedimientos de Cirugía Plástica/psicología , Umbral Sensorial , Encuestas y Cuestionarios , Tacto
17.
Int J Oral Maxillofac Implants ; 21(6): 951-6, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17190306

RESUMEN

PURPOSE: Since 1997, the use of highly active antiretroviral therapy (HAART) has significantly improved systemic health and life expectancy of patients who test positive for the human immunodeficiency virus (HIV) in industrialized countries. Therefore, although implant-supported prosthetic rehabilitation has been restricted to immunocompetent individuals, it may be considered for these patients. CASE REPORTS: The treatment course of implant-prosthetic rehabilitation in 3 patients is reported. Patient 1 (male, age 64 years) was under 4-drug therapy; patient 2 (male, age 38 years) and patient 3 (female, age 49 years) were under 3-drug therapy. Two patients had suffered from AIDS-defining diseases prior to HAART. Oral manifestations of HIV infection were not diagnosed throughout the observation period. Patients had CD4+ cell counts between 250 and 800/mL, and viral load was below 50/mL. Perioperative antibiotic treatment was not applied. Two patients presented with edentulous mandibles. In the third patient, single-tooth replacement of both mandibular first molars was performed. A total of 10 Frialit-2 implants were placed without augmentation procedures. RESULTS: One implant failed after 3 months and was successfully replaced. Two patients received magnet-retained overdentures in the mandible, and 1 patient was treated with single crowns. All implants and restorations are successfully in function. Neither radiographic nor clinical signs of inflammation were detected during the observation period (range, 7 to 32 months). CONCLUSIONS: The outcomes of the 3 patients suggest that immunologically stable HIV-positive patients on HAART may be considered for implant-prosthetic rehabilitation.


Asunto(s)
Terapia Antirretroviral Altamente Activa , Implantes Dentales , Prótesis Dental de Soporte Implantado , Infecciones por VIH/tratamiento farmacológico , Adulto , Recuento de Linfocito CD4 , Coronas , Atención Dental para Enfermos Crónicos , Implantes Dentales de Diente Único , Fracaso de la Restauración Dental , Dentadura Completa Inferior , Prótesis de Recubrimiento , Femenino , Estudios de Seguimiento , Humanos , Arcada Edéntula/rehabilitación , Arcada Edéntula/cirugía , Masculino , Mandíbula/cirugía , Persona de Mediana Edad , Diente Molar , Retratamiento , Carga Viral
18.
Oral Oncol ; 40(8): 824-8, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15288838

RESUMEN

In this study, we compared 103 OralCDx results with the histological findings of 96 clinical sites in 80 patients (33 females; 64.3+/-13.7 years and 47 males; 53.2+/-11.5 years). The histological findings were classified as follows: compatible with oral leukoplakia (OL; n = 60) or oral lichen planus (OLP; n = 17), both without dysplasia; dysplasia in OL or OLP (n = 9); and oral squamous cell carcinoma (OSCC; n = 17). There were seven (6.8%) specimens with an inadequate cell count. Overall, the sensitivity of the OralCDx technique to detect dysplasia and OSCC was 92.3% (95% CI: 74.9-99.1%), and the specificity was 94.3% (95% CI: 86.0-98.4%). The positive likelihood ratio (LR+) was 16.2 (95% CI: 6.2-42.1) and the negative likelihood ratio (LR-) was 0.08 (95% CI: 0.02-0.31). In conclusion, these figures are in agreement with previously published data and support the use of OralCDx as a screening tool of oral lesions, but further trials are still necessary.


Asunto(s)
Leucoplasia Bucal/patología , Mucosa Bucal/patología , Biopsia/métodos , Diagnóstico por Computador/métodos , Femenino , Humanos , Leucoplasia Bucal/diagnóstico , Liquen Plano Oral/diagnóstico , Liquen Plano Oral/patología , Funciones de Verosimilitud , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/diagnóstico , Neoplasias de la Boca/patología , Sensibilidad y Especificidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...